|
|
|
|
New Luminex High
Performance Cytokine 45-Plex!
45°¡Áö cytokinesÀ» ÇϳªÀÇ Æгο¡¼ ¸¸³ª º¸½Ç ¼ö ÀÖ½À´Ï´Ù. °æÀï»ç Á¦Ç°µé°ú
side-by-side test±îÁö ¿Ï·á ÇÏ¿© »õ·Ó°Ô Ãâ½Ã ÇÑ Human XL Cytokine
Discovery PanelÀÇ QC data¸¦ Áö±Ý È®ÀÎÇØ º¸½Ã±â ¹Ù¶ø´Ï´Ù!
|
|
|
|
Butyrophilins:
Novel Immunomodulatory Proteins with Structure and Functions Similar to the
B7 Family
Explore ÇöÀç ÀÌ¿ë °¡´ÉÇÑ »õ·Î¿î
bioactive butyrophilin proteins¿Í À̵é novelÇÑ immuno-oncology
drug targetµéÀÇ immunosuppressive activity¸¦ º¸¿©ÁÖ´Â data¸¦ Áö±Ý È®ÀÎÇØ º¸¼¼¿ä.
|
|
|
|
New Human CD28
DuoSet® ELISA Development System
CD28 ¿Í CTLA-4´Â, ±×µéÀÇ ligandsÀÎ, B7-1 °ú B7-2¿Í ÇÔ²², T ¹× B cell responses¸¦ Á¶ÀýÇÏ´Â ÁÖ¿ä co-stimulatory
pathways Áß Çϳª¸¦ ±¸¼ºÇÑ´Ù. ¿ì¸®ÀÇ ÀϹÝÀûÀÎ ELISA
systemÀ¸·Î human CD28 protein levels¸¦ Á¤·®ÇÒ ¼ö ÀÖ½À´Ï´Ù.
|
|
|
|
Review of the
Immunoregulatory Functions of VISTA
ÃàÀûµÈ Áõ°Åµé¿¡¼ VISTA/VSIG-3
co-inhibitory pathway°¡ metastatic
melanoma¿¡¼ PD-1 ¾ïÁ¦¿¡ ´ëÇÑ È¹µæ µÈ ³»¼ºÀ» ±Øº¹Çϱâ À§ÇÑ potential targetÀÌ µÉ ¼ö ÀÖÀ½À» ½Ã»çÇÏ°í ÀÖ´Ù. Nowak, et
al.ÀÇ ÀÌreview ´Â cancer
immunotherapy¿Í °ü·ÃÇÏ¿© VISTAÀÇ ±â´ÉÀ» ¼³¸íÇÕ´Ï´Ù.
|
|
|
|
Webinar: Next
Generation Targets for Immuno-Oncology
R&D Systems Development ScientistÀÎ Anthony
Person Ph.D.´Â, VISTA, B7-related
butyrophilins¹× novel
LILRA/B interactionsÀ» À§ÇÑ novel immunosuppressive protein ¹× ligand·Î½á VSIG3À» °Á¶ÇÏ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù webinar ¿¡¼ À̵é moleculesÀÇ immunomodulatory
functions¿¡ ´ëÇØ ¹è¿ï ¼ö ÀÖ½À´Ï´Ù.
|
|
|
|
Explore R&D
Systems® Collection of Products for T Cell Co-Signaling Research
T cell activation˼ multiple
co-stimulatory ¹×co-inhibitory
molecules¿¡ ÀÇÇØ Á¶ÀýµË´Ï´Ù. R&D Systems´Â À̵é T cell co-signaling molecules ÀÇ functionµéÀ» ¿¬±¸Çϱâ À§ÇÑ recombinant
proteins, antibodies, ELISA Kits, ±×¸®°í multiplex assays¸¦ Á¦°øÇÕ´Ï´Ù. ¿ì¸®ÀÇ ÃֽŠbrochure¸¦ ÅëÇØ ´õ ÀÚ¼¼È÷ ¾Ë¾Æº¸¼¼¿ä!
|
|
|
|
Multicolor Flow
Cytometry Video Tutorial
Novus Panel Builder¿¡ °üÇÑ ÀÌ video ÀÚ½À¼´Â 3ºÐ ¾È¿¡ multicolor flow cytometry pane ¼³°è¿¡ ´ëÇÑ ±âº»À» °¡¸£ÃÄ ÁÝ´Ï´Ù. Watch the video!
|
|
|
|
Role of TLR4 in
Cancer Immunomodulation
AwasthiÀÇ paper´Â inflammation-induced carcinogenesis ÀÇ ¾ïÁ¦¿¡¼ TLR4
ligandsÀÇ »ç¿ë¿¡ ´ëÇØ ³íÀÇÇÏ°í ÀÖ½À´Ï´Ù. LPS-induced
NF-¥êB activation À» ¾ïÁ¦ÇÏ´Â °ÍÀ¸·Î ¹àÇôÁø TocrisÀÇ TLR4¾ïÁ¦Á¦ÀÎ, M62812¸¦ È®ÀÎÇϼ¼¿ä.
|
|
|
|
New Human IFN-beta
Quantikine® ELISA Kit
´õ sensitiveÇÑ new
Human IFN-beta ELISA kit¸¦ ÀÌÁ¦ R&D Systems¿¡¼ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. Ready-to-use ÇÑ ÀÌ ELISA kit´Â cell culture supernate¿¡¼
IFN-beta ¸¦ ÃøÁ¤ÇÒ ¶§ Ź¿ùÇÑ ¼º´É°ú ÀÏ°ü¼ºÀ» ÀÔÁõ ¹Þ¾Ò½À´Ï´Ù.
|
|
Bio-Techne at Upcoming Meetings
|
1st Crick International Cancer
Conference
London, United Kingdom, Sept. 24-26, 2017
CCRL 2017: 3rd International
Symposium of the Cancer Research Center of Lyon
Lyon, France, Sept. 25-27, 2017
European Society of Gene and Cell
Therapy 2017
Berlin, Germany, Oct. 17-20, 2017
European Antibody Congress 2017
Basel, Switzerland, Oct. 31-Nov. 2, 2017
3rd Annual Cell & Gene
Therapy Congress 2017
London, United Kingdom, Nov. 6-7, 2017
|
|
|
|
Have a product suggestion? Let us know here!
|